Dr. Jennifer Spronck

Jennifer Spronck drafts, prosecutes, and completes patents in the fields of biochemistry, cellular and molecular biology, toxicology, and nutrition, with an emphasis on cancer research; specifically including DNA damage/repair, genomic stability, and alterations of gene expression. On behalf of clients, Jennifer regularly corresponds with foreign associates to ensure clients' worldwide IP protection.

Jennifer’s extensive research background includes investigating the role(s) of niacin nutrition in the maintenance of genomic stability as well as the identification of DNA-nutrient interactions that modulate cancer risk and alter cellular sensitivity to chemotherapeutic agents. At the Ottawa Regional Cancer Centre, she worked on the analysis of p53 regulated gene expression and the identification of novel genes involved in tumour suppression and DNA repair.

Jennifer is a Registered Canadian Patent Agent.

Education

• B.Sc., Biomedical Toxicology, University of Guelph
• Ph.D., Nutritional Toxicology, University of Guelph
• Post-Doctoral Associate, Ottawa Regional Cancer Centre

Professional Involvement

• Intellectual Property Institute of Canada (IPIC)